1996 | Phantom상 내경동맥기시부 협착에 따른 혈류변화 : 자기공명혈관촬영술 디지탈감산 혈관촬영술, 전산유체역학과의 비교
| Journal of the Korean Radiologist Society(대한방사선의학회지) |
2005 | Pharaoh Ant (Monomorium pharaonis): Newly Identified Important Inhalant Allergens in Bronchial Asthma
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2020 | Pharmaceutical Efficacy of Gypenoside LXXV on Non-Alcoholic Steatohepatitis (NASH)
| BIOMOLECULES |
2021 | Pharmaco-proteogenomic characterization of glioblastoma
| Dissertation |
2022 | Pharmacodynamic analysis of intravenous bolus remimazolam for loss of consciousness in patients undergoing general anaesthesia: a randomised, prospective, double-blind study | BRITISH JOURNAL OF ANAESTHESIA |
2021 | Pharmacodynamic Biomarkers Predictive of Survival Benefit with Lenvatinib in Unresectable Hepatocellular Carcinoma: From the Phase III REFLECT Study | CLINICAL CANCER RESEARCH |
2007 | Pharmacodynamic characteristics and cardioprotective effects of new NHE1 inhibitors | EUROPEAN JOURNAL OF PHARMACOLOGY |
2015 | Pharmacodynamic Estimate of Propofol-Induced Sedation and Airway Obstruction Effects in Obstructive Sleep Apnea-Hypopnea Syndrome
| YONSEI MEDICAL JOURNAL |
2020 | Pharmacodynamic evaluation of YH4808 for Helicobacter pylori eradication in healthy subjects
| Translational and Clinical Pharmacology |
2016 | Pharmacogenetic analysis of advanced non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin chemotherapy | PHARMACOGENETICS AND GENOMICS |
2013 | Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patients | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
2020 | Pharmacogenomic Analysis Reveals CCNA2 as a Predictive Biomarker of Sensitivity to Polo-Like Kinase I Inhibitor in Gastric Cancer
| CANCERS |
2020 | Pharmacogenomic analysis reveals CCNA2 as a predictive biomarker of sensitivity to polo-like kinaseⅠ inhibitor in gastric cancer
| Thesis |
2013 | Pharmacogenomic Assessment of Outcomes of Pemetrexed-Treated Patients with Adenocarcinoma of the Lung
| YONSEI MEDICAL JOURNAL |
2005 | Pharmacogenomic markers predicting toxicity and response of gemcitabine in breast cancer patients
| Thesis |
2007 | Pharmacokinetic and pharmacodynamic consequences of inhibition of terazosin metabolism via CYP3A1 and/or 3A2 by DA-8159, an erectogenic, in rats
| BRITISH JOURNAL OF PHARMACOLOGY |
2021 | Pharmacokinetic and pharmacodynamic evaluation of local minocycline agents in treating peri-implant mucositis and peri-implantitis: An experimental in vivo study
| Dissertation |
2023 | Pharmacokinetic and pharmacodynamic interaction of DWP16001, a sodium-glucose cotransporter-2 inhibitor, with phentermine in healthy subjects | Expert Opinion on Drug Metabolism & Toxicology |
2017 | Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patients | JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS |
2005 | Pharmacokinetic changes of DA-7867, a new oxazolidinone, after intravenous and oral administration to rats with short-term and long-term diabetes mellitus induced by streptozotocin | EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES |